Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.26.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 139 $ 64,372,486 $ (7,171) $ (49,582,778) $ 14,782,676
Balance (in Shares) at Dec. 31, 2024 1,394,263        
-stock options 96,985 96,985
-warrants 1,573 1,573
Issuance of common stock at-the-market for cash, net of offering costs $ 44 1,652,701 1,652,745
Issuance of common stock at-the-market for cash, net of offering costs (in Shares) 440,000        
Issuance of common stock for exercise of pre-funded warrants $ 87 784 871
Issuance of common stock for exercise of pre-funded warrants (in Shares) 871,000        
Realized foreign currency translation loss from dissolution of subsidiaries 7,171 7,171
Net loss (3,563,238) (3,563,238)
Balance at Mar. 31, 2025 $ 270 66,124,529 (53,146,016) 12,978,783
Balance (in Shares) at Mar. 31, 2025 2,705,263        
Balance at Dec. 31, 2025 $ 2,309 125,208,624 18,766 (70,010,461) 55,219,238
Balance (in Shares) at Dec. 31, 2025 23,091,062        
-stock options 138,364 138,364
-warrants 817 817
Issuance of common stock for exercise of pre-funded warrants $ 75 675 750
Issuance of common stock for exercise of pre-funded warrants (in Shares) 750,000        
Issuance of common stock for cashless exercise of pre-funded warrants $ 110 (110)
Issuance of common stock for cashless exercise of pre-funded warrants (in Shares) 1,098,886        
Reclassification to equity of the Placement Agent Warrants Liability 2,294,631 2,294,631
Realized foreign currency translation loss from dissolution of subsidiaries 28,132 28,132
Net loss (2,869,482) (2,869,482)
Balance at Mar. 31, 2026 $ 2,494 $ 127,643,001 $ 46,898 $ (72,879,943) $ 54,812,450
Balance (in Shares) at Mar. 31, 2026 24,939,948